The European Medicines Agency’s drug evaluation committee, the CHMP, has given an opinion endorsing the use of dexamethasone as a treatment option for hospitalized COVID-19 patients who require oxygen therapy.
Companies already marketing the corticosteroid have been told by the agency that they can request this new use to be...








